BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El Rouby N, Rodrigues Marcatto L, Claudio K, Camargo Tavares L, Steiner H, Botton MR, Lubitz SA, Fallon EN, Yee K, Kaye J, Scott SA, Karnes J, Caleb Junior de Lima Santos P, Duconge J, Cavallari LH. Multi-site Investigation of Genetic Determinants of Warfarin Dose Variability in Latinos. Clin Transl Sci 2021;14:268-76. [PMID: 32860733 DOI: 10.1111/cts.12854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hirata TDC, Dagli-Hernandez C, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients. Mol Diagn Ther 2021. [PMID: 34357562 DOI: 10.1007/s40291-021-00549-z] [Reference Citation Analysis]
2 Tian L, Xiao P, Zhou B, Chen Y, Kang L, Wang Q, Lin J, Son M, Wu Q. Influence of NQO1 Polymorphisms on Warfarin Maintenance Dose: A Systematic Review and Meta-Analysis (rs1800566 and rs10517). Cardiovasc Ther 2021;2021:5534946. [PMID: 34457036 DOI: 10.1155/2021/5534946] [Reference Citation Analysis]
3 Steiner HE, Giles JB, Patterson HK, Feng J, El Rouby N, Claudio K, Marcatto LR, Tavares LC, Galvez JM, Calderon-Ospina CA, Sun X, Hutz MH, Scott SA, Cavallari LH, Fonseca-Mendoza DJ, Duconge J, Botton MR, Santos PCJL, Karnes JH. Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans. Front Pharmacol 2021;12:749786. [PMID: 34776967 DOI: 10.3389/fphar.2021.749786] [Reference Citation Analysis]